UNSPSC 51101643: Carbarsone

This classification denotes an antiprotozoal agent with the molecular formula C7H9AsN2O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8PK70TXE1T, chemically known as benzenearsonic acid, p-ureido- but generally known as carbarsone, which bears US NIH Compound Identifier 8480. Carbarsone most often comes in base, oxide, and sodium forms. European Medicines Agency schedules Carbarsone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06116MIG.

UNSPSC 51101643 Carbarsone, a Commodity code, does not align with the recent state and local solicitations tagged under it. The code nominally describes carbarsone, a veterinary antiprotozoal agent, but the opportunities posted under this code procure naloxone (an opioid antagonist), safe drug deactivation systems, generic multi-source pharmaceuticals and over-the-counter products, and therapeutic pharmacy initiatives—none of which are carbarsone or veterinary products. The mismatch suggests a tagging or classification error in the underlying procurement database rather than authentic demand for the commodity itself. State and local buyers issuing under this code include county health departments (Seminole County, Florida), state health agencies (Texas Health and Human Services Commission), municipal fire departments (City of Tampa), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance). The actual work being solicited reflects demand for emergency-response pharmaceuticals, opioid-reversal agents, pharmacy benefit management infrastructure, and consumable medical supplies for fire-rescue operations.

Geographic activity centers on Florida, Texas, Minnesota, and Oregon, with representation across municipal, county, and state-level procurement offices. Representative recent opportunities include Seminole County, Florida's invitation for bid (IFB 60459723LAS, response due July 26, 2023) seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually for community health initiatives; the City of Tampa's sealed-bid solicitation (26P00145, due March 13, 2026) for 169 line items of medical and first aid supplies for the Fire Department Rescue Division, with an estimated contract value of $700,000.00 and a Small Local Business Enterprise set-aside; the Texas Health and Human Services Commission's request for information (RFI HHS0017013, posted April 3, 2026) exploring direct-to-manufacturer prescription programs; and the Minnesota Multistate Cooperative Purchasing Alliance's RFP (S1070000015802, due March 26, 2026) for generic multi-source pharmaceuticals and OTC products distributed through AmerisourceBergen, Cardinal Health, and Morris & Dickson. The code shows minimal relevant recent activity tied to its nominal scope.